Another busy week at Retraction Watch, which we kicked off by asking for your support. Have you contributed yet? Here’s what was happening elsewhere on the web:
We’ve reported on some pretty impressive cases of researchers doing their own peer review, one of which led to 28 retractions. We have another. Yongdeng Lei, of the School of Geography and Remote Sensing Science at Beijing Normal University, pulled the wool over the eyes of two Springer journals. Here’s the notice from Environmental Management … Continue reading Want to make sure your paper gets published? Just do your own peer review like this researcher did
Retraction Watch readers may recall that in November, we, along with Automattic, the company behind WordPress, filed a lawsuit against someone who filed a false copyright infringement claim about ten of our posts. On a false pretense — copying and pasting the posts onto a website in India, then claiming that we had plagiarized that … Continue reading Fight against false copyright claims goes to Capitol Hill
March has come in like a lion for the folks at the Office of Research Integrity (ORI). The agency’s director, David Wright, stepped down late last month for reasons that even now remain unclear. And in what seems to be an unrelated development, ORI has managed to draw the ire of Sen. Charles Grassley, who … Continue reading Senator “unsatisfied” with ORI’s response on recovery of tainted grant money
A co-author of two papers claiming to have shown how to create stem cells simply and easily has requested their retraction, the Wall Street Journal is reporting:
Another busy week at Retraction Watch, including a ScienceOnline 2014 session Ivan facilitated on post-publication peer review. Here’s a selection of what was happening elsewhere on the web:
AAPS PharmSciTech, a journal of the American Association of Pharmaceutical Scientists, has retracted a 2013 paper by a group from India. The reason appears to be manipulated data, although the wording of the notice leaves that open to interpretation. The article, “Design and Formulation Technique of a Novel Drug Delivery System for Azithromycin and Its … Continue reading Pharmaceutical journal retracts antibiotics paper with dodgy data, with an unclear notice
Denis de Jesus Lima Guerra, a co-author on 11 chemistry papers that were retracted in 2011 for suspicions of fraud, has lost his position at the Federal University of Mato Grosso (UFMT). Bernardo Esteves, who was first to report the news, writes (courtesy Google Translate) that the dismissal was
Another busy week at Retraction Watch. Here’s a sampling of items about scientific publishing, research misconduct, and related issues from around the web:
One of the issues that comes up frequently when we’re moderating comments here on Retraction Watch is the distinction between “I think these images look strange” and “this researcher committed fraud.” That’s a pretty important distinction, because potentially actionable cases of libel live somewhere in between, probably closer to the latter — as Paul Brookes … Continue reading Where’s the line between scientific post-publication peer review critiques and libel?